Search research articles
Contact Us
Filters
Showing results (41-50 of 240) with videos related to
Page
of 24
Sort By:
Bulletin Du Cancer
|
June 30, 2015
[Pancreatic adenocarcinoma: 10 years of progress]
Pascal Hammel, Cindy Neuzillet, Sihem Bendaoud, et al.
European Journal of Gastroenterology & Hepatology
|
November 30, 2011
Do guidelines influence medical practice? Changes in management of acute pancreatitis 7 years after the publication of the French guidelines
Vinciane Rebours, Philippe Lévy, Jean-François Bretagne, et al.
Journal of Clinical Pathology
|
October 31, 2013
EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins
Adriana Handra-Luca, Pascal Hammel, Alain Sauvanet, et al.
Cancers
|
December 29, 2020
Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021
Anthony Turpin, Mehdi El Amrani, Jean-Baptiste Bachet, et al.
Targeted Oncology
|
June 5, 2012
Sunitinib in pancreatic neuroendocrine tumors
Eric Raymond, Pascal Hammel, Chantal Dreyer, et al.
Molecular and Clinical Oncology
|
August 6, 2020
Cervical bone pain revealing a bone metastatic colon cancer: A case report
Yaqoub Alshatti, Shuaib Alqallaf, Wassim Allaham, et al.
Gastroenterologie Clinique Et Biologique
|
February 3, 2007
[Metastatic transitional cell carcinoma with high CA 19.9 serum levels]
Jean-Yves Camain, Pascal Hammel, Dominique Cazals-Hatem, et al.
Gastroenterologie Clinique Et Biologique
|
March 4, 2006
[Gastric perforation by histoacryl extravasation as a complication of endoscopic sclerotherapy for bleeding Dieulafoy ulcer]
Alain Aubert, Pascal Hammel, Magali Zappa, et al.
Nature Reviews. Clinical Oncology
|
April 1, 2016
Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease
Xavier M Keutgen, Pascal Hammel, Peter L Choyke, et al.
BMC Cancer
|
October 8, 2015
A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trial
Jean-Baptiste Bachet, Benoist Chibaudel, Franck Bonnetain, et al.
Page
of 24
Search research articles
Search
Showing results (41-50 of 240) with videos related to
Sort By:
Page
of 24
Bulletin Du Cancer
|
June 30, 2015
[Pancreatic adenocarcinoma: 10 years of progress]
Pascal Hammel, Cindy Neuzillet, Sihem Bendaoud, et al.
European Journal of Gastroenterology & Hepatology
|
November 30, 2011
Do guidelines influence medical practice? Changes in management of acute pancreatitis 7 years after the publication of the French guidelines
Vinciane Rebours, Philippe Lévy, Jean-François Bretagne, et al.
Journal of Clinical Pathology
|
October 31, 2013
EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins
Adriana Handra-Luca, Pascal Hammel, Alain Sauvanet, et al.
Cancers
|
December 29, 2020
Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021
Anthony Turpin, Mehdi El Amrani, Jean-Baptiste Bachet, et al.
Targeted Oncology
|
June 5, 2012
Sunitinib in pancreatic neuroendocrine tumors
Eric Raymond, Pascal Hammel, Chantal Dreyer, et al.
Molecular and Clinical Oncology
|
August 6, 2020
Cervical bone pain revealing a bone metastatic colon cancer: A case report
Yaqoub Alshatti, Shuaib Alqallaf, Wassim Allaham, et al.
Gastroenterologie Clinique Et Biologique
|
February 3, 2007
[Metastatic transitional cell carcinoma with high CA 19.9 serum levels]
Jean-Yves Camain, Pascal Hammel, Dominique Cazals-Hatem, et al.
Gastroenterologie Clinique Et Biologique
|
March 4, 2006
[Gastric perforation by histoacryl extravasation as a complication of endoscopic sclerotherapy for bleeding Dieulafoy ulcer]
Alain Aubert, Pascal Hammel, Magali Zappa, et al.
Nature Reviews. Clinical Oncology
|
April 1, 2016
Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease
Xavier M Keutgen, Pascal Hammel, Peter L Choyke, et al.
BMC Cancer
|
October 8, 2015
A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trial
Jean-Baptiste Bachet, Benoist Chibaudel, Franck Bonnetain, et al.
Page
of 24